Fulcrum Therapeutics
Price & Volume
Stats
See moreOpen | $8.15 |
Previous Close | $8.15 |
Day Range | $8.01-$8.34 |
52W Range | $2.31-$10.11 |
Market Cap | $441M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$52.4M |
Diluted EPS | -$1.14 |
News
See moreYahoo Finance • 5 days ago
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 7 days ago
Caterpillar upgraded, Elf Beauty downgraded: Wall Street's top analyst calls
Yahoo Finance • 15 days ago
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2025
About
CEO | Mr. Alexander C. Sapir |
Address | 26 Landsdowne Street, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 45 |
